Gilead Sciences Revenue 2006-2018 | GILD

Gilead Sciences annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Gilead Sciences revenue for the quarter ending December 31, 2018 was $5.795B, a 2.59% decline year-over-year.
Gilead Sciences revenue for the twelve months ending December 31, 2018 was $22.127B, a 15.24% decline year-over-year.
Gilead Sciences annual revenue for 2018 was $22.127B, a 15.24% decline from 2017.
Gilead Sciences annual revenue for 2017 was $26.107B, a 14.09% decline from 2016.
Gilead Sciences annual revenue for 2016 was $30.39B, a 6.89% decline from 2015.

Gilead Sciences Annual Revenue (Millions of US $)
2018	$22,127
2017	$26,107
2016	$30,390
2015	$32,639
2014	$24,890
2013	$11,202
2012	$9,702
2011	$8,385
2010	$7,949
2009	$7,011
2008	$5,336
2007	$4,230
2006	$3,026
2005	$2,028

Gilead Sciences Quarterly Revenue (Millions of US $)
Q4 2018	$5,795
Q3 2018	$5,596
Q2 2018	$5,648
Q1 2018	$5,088
Q4 2017	$5,949
Q3 2017	$6,512
Q2 2017	$7,141
Q1 2017	$6,505
Q4 2016	$7,320
Q3 2016	$7,500
Q2 2016	$7,776
Q1 2016	$7,794
Q4 2015	$8,506
Q3 2015	$8,295
Q2 2015	$8,244
Q1 2015	$7,594
Q4 2014	$7,314
Q3 2014	$6,042
Q2 2014	$6,535
Q1 2014	$4,999
Q4 2013	$3,120
Q3 2013	$2,783
Q2 2013	$2,767
Q1 2013	$2,532
Q4 2012	$2,588
Q3 2012	$2,427
Q2 2012	$2,405
Q1 2012	$2,282
Q4 2011	$2,200
Q3 2011	$2,122
Q2 2011	$2,137
Q1 2011	$1,926
Q4 2010	$1,999
Q3 2010	$1,938
Q2 2010	$1,927
Q1 2010	$2,086
Q4 2009	$2,032
Q3 2009	$1,801
Q2 2009	$1,647
Q1 2009	$1,530
Q4 2008	$1,428
Q3 2008	$1,371
Q2 2008	$1,278
Q1 2008	$1,258
Q4 2007	$1,095
Q3 2007	$1,059
Q2 2007	$1,048
Q1 2007	$1,028
Q4 2006	$899
Q3 2006	$749
Q2 2006	$685
Q1 2006	$693
Q4 2005	$609
Q3 2005	$493
Q2 2005	$495
Q1 2005	$430

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$82.321B	$22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$115.829B	13.05
Celgene (CELG)	United States	$66.417B	12.28
Illumina (ILMN)	United States	$48.412B	57.60
Vertex Pharmaceuticals (VRTX)	United States	$45.952B	61.56
Biogen (BIIB)	United States	$44.991B	8.72
Regeneron Pharmaceuticals (REGN)	United States	$40.180B	18.66
Alexion Pharmaceuticals (ALXN)	United States	$30.602B	18.97
Incyte (INCY)	United States	$16.494B	153.96
BioMarin Pharmaceutical (BMRN)	United States	$15.788B	0.00
Seattle Genetics (SGEN)	United States	$12.345B	0.00
Exact Sciences (EXAS)	United States	$11.974B	0.00
Alnylam Pharmaceuticals (ALNY)	United States	$9.414B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.133B	52.39
QIAGEN (QGEN)	Netherlands	$8.959B	29.65
Sarepta Therapeutics (SRPT)	United States	$8.668B	0.00
Bluebird Bio (BLUE)	United States	$8.464B	0.00
Moderna (MRNA)	United States	$7.824B	0.00
BeiGene (BGNE)	Cayman Islands	$7.681B	0.00
Bio-Techne Corp (TECH)	United States	$7.375B	49.69
Exelixis (EXEL)	United States	$6.886B	15.98
Guardant Health (GH)	United States	$6.584B	0.00
Galapagos (GLPG)	Belgium	$5.979B	0.00
Amarin (AMRN)	Ireland	$5.938B	0.00
Alkermes (ALKS)	Ireland	$5.370B	0.00
Array BioPharma (ARRY)	United States	$5.119B	0.00
Horizon Pharma Public (HZNP)	Ireland	$4.727B	14.01
Ascendis Pharma (ASND)	Denmark	$4.688B	0.00
Spark Therapeutics (ONCE)	United States	$4.208B	0.00
ARGENX SE-ADR (ARGX)	Netherlands	$3.945B	0.00
China Biologic Products (CBPO)	China	$3.812B	23.62
ACADIA Pharmaceuticals (ACAD)	United States	$3.670B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$3.503B	0.00
Blueprint Medicines (BPMC)	United States	$3.444B	0.00
Immunomedics (IMMU)	United States	$3.331B	0.00
Global Blood Therapeutics (GBT)	United States	$3.285B	0.00
Allogene Therapeutics (ALLO)	United States	$3.191B	0.00
MorphoSys AG Unsponsored ADR (MOR)	Germany	$3.107B	0.00
Amicus Therapeutics (FOLD)	United States	$3.051B	0.00
Biohaven Pharmaceutical Holding (BHVN)	United States	$2.741B	0.00
Intercept Pharmaceuticals (ICPT)	United States	$2.723B	0.00
Emergent Biosolutions (EBS)	United States	$2.720B	22.62
Akcea Therapeutics (AKCA)	United States	$2.593B	0.00
Denali Therapeutics (DNLI)	United States	$2.552B	0.00
Ligand Pharmaceuticals (LGND)	United States	$2.550B	19.04
Insmed (INSM)	United States	$2.497B	0.00
Reata Pharmaceuticals (RETA)	United States	$2.457B	0.00
Repligen (RGEN)	United States	$2.430B	74.76
Myriad Genetics (MYGN)	United States	$2.418B	24.63
Halozyme Therapeutics (HALO)	United States	$2.415B	0.00
Genomic Health (GHDX)	United States	$2.406B	61.51
Arena Pharmaceuticals (ARNA)	United States	$2.357B	0.00
Acceleron Pharma (XLRN)	United States	$2.253B	0.00
Mirati Therapeutics (MRTX)	United States	$2.248B	0.00
Medicines (MDCO)	United States	$2.129B	0.00
UniQure (QURE)	Netherlands	$2.129B	0.00
AnaptysBio (ANAB)	United States	$2.088B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$2.043B	0.00
MyoKardia (MYOK)	United States	$2.007B	0.00
REGENXBIO (RGNX)	United States	$1.965B	20.41
NeoGenomics (NEO)	United States	$1.951B	158.69
Nabriva Therapeutics AG (NBRV)	Ireland	$1.882B	0.00
Audentes Therapeutics (BOLD)	United States	$1.750B	0.00
Zai Lab Unsponsored ADR (ZLAB)	China	$1.736B	0.00
Alector (ALEC)	United States	$1.715B	0.00
Orchard Therapeutics Sponsored ADR (ORTX)	United Kingdom	$1.654B	0.00
Atara Biotherapeutics (ATRA)	United States	$1.647B	0.00
Allakos (ALLK)	United States	$1.594B	0.00
Rubius Therapeutics (RUBY)	United States	$1.501B	0.00
Myovant Sciences (MYOV)	United Kingdom	$1.411B	0.00
Innoviva (INVA)	United States	$1.393B	3.84
Lion Biotechnologies (IOVA)	United States	$1.392B	0.00
Momenta Pharmaceuticals (MNTA)	United States	$1.392B	0.00
Editas Medicine (EDIT)	United States	$1.336B	0.00
Aimmune Therapeutics (AIMT)	United States	$1.336B	0.00
Cambrex (CBM)	United States	$1.324B	14.25
InflaRx (IFRX)	Germany	$1.313B	0.00
Puma Biotechnology (PBYI)	United States	$1.304B	0.00
Sangamo Therapeutics (SGMO)	United States	$1.226B	0.00
Apellis Pharmaceuticals (APLS)	United States	$1.209B	0.00
Epizyme (EPZM)	United States	$1.201B	0.00
Gossamer Bio (GOSS)	United States	$1.146B	0.00
Clovis Oncology (CLVS)	United States	$1.124B	0.00
Codexis (CDXS)	United States	$1.115B	0.00
Autolus Therapeutics Sponsored ADR (AUTL)	United Kingdom	$1.080B	0.00
Fate Therapeutics (FATE)	United States	$1.073B	0.00
Coherus BioSciences (CHRS)	United States	$1.046B	0.00
NGM BIOPHARMACT (NGM)	United States	$1.018B	0.00
Clementia Pharmaceuticals (CMTA)	Canada	$1.004B	0.00
Dicerna Pharmaceuticals (DRNA)	United States	$0.993B	0.00
Genfit SA (GNFT)	France	$0.946B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.934B	0.00
RA PHARMCTL INC (RARX)	United States	$0.925B	0.00
Eidos Therapeutics (EIDX)	United States	$0.921B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.917B	37.06
Rhythm Pharmaceuticals (RYTM)	United States	$0.911B	0.00
Kiniksa Pharmaceuticals (KNSA)	Bermuda	$0.903B	0.00
Deciphera Pharmaceuticals (DCPH)	United States	$0.898B	0.00
Retrophin (RTRX)	United States	$0.877B	0.00
Y-mAbs Therapeutics (YMAB)	United States	$0.843B	0.00
WAVE Life Sciences (WVE)	Singapore	$0.837B	0.00
Cellectis (CLLS)	France	$0.832B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.813B	14.88
Vericel (VCEL)	United States	$0.811B	0.00
Inotek Pharmaceuticals (RCKT)	United States	$0.807B	0.00
Twist Bioscience (TWST)	United States	$0.789B	0.00
Intellia Therapeutics (NTLA)	United States	$0.786B	0.00
Athenex (ATNX)	United States	$0.782B	0.00
Cara Therapeutics (CARA)	United States	$0.762B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.721B	0.00
Arvinas (ARVN)	United States	$0.717B	0.00
Nightstar Therapeutics Sponsored ADR (NITE)	United Kingdom	$0.716B	0.00
Intra-Cellular Therapies (ITCI)	United States	$0.698B	0.00
Principia Biopharma (PRNB)	United States	$0.695B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.670B	0.00
G1 THERAPEUTICS (GTHX)	United States	$0.664B	0.00
Viking Therapeutics (VKTX)	United States	$0.658B	0.00
Osiris Therapeutics (OSIR)	United States	$0.656B	0.00
Precision BioSciences (DTIL)	United States	$0.650B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.626B	0.00
Revance Therapeutics (RVNC)	United States	$0.614B	0.00
Stemline Therapeutics (STML)	United States	$0.610B	0.00
ObsEva SA (OBSV)	Switzerland	$0.603B	0.00
Synthorx (THOR)	United States	$0.591B	0.00
Kura Oncology (KURA)	United States	$0.585B	0.00
Heska (HSKA)	United States	$0.578B	51.85
Zealand Pharma (ZEAL)	Denmark	$0.570B	6.35
Acorda Therapeutics (ACOR)	United States	$0.568B	7.36
Arcus Biosciences (RCUS)	United States	$0.545B	0.00
Mesoblast (MESO)	Australia	$0.541B	0.00
DBV Technologies (DBVT)	France	$0.537B	0.00
Magenta Therapeutics (MGTA)	United States	$0.532B	0.00
UROGEN PHARMA (URGN)	United States	$0.526B	0.00
Axsome Therapeutics (AXSM)	United States	$0.515B	0.00
Zymeworks (ZYME)	Canada	$0.509B	0.00
AVROBIO (AVRO)	United States	$0.498B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.496B	0.00
CytomX Therapeutics (CTMX)	United States	$0.476B	0.00
PDL BioPharma (PDLI)	United States	$0.473B	10.54
ProQR Therapeutics (PRQR)	Netherlands	$0.468B	0.00
CYCLERION THERA (CYCN)	United States	$0.464B	0.00
Cytokineticsorporated (CYTK)	United States	$0.460B	0.00
Anika Therapeutics (ANIK)	United States	$0.457B	17.30
Five Prime Therapeutics (FPRX)	United States	$0.453B	0.00
NuCana Sponsored ADR (NCNA)	United Kingdom	$0.451B	0.00
Krystal Biotech (KRYS)	United States	$0.444B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.444B	0.00
Prothena (PRTA)	Ireland	$0.436B	0.00
Achillion Pharmaceuticals (ACHN)	United States	$0.434B	0.00
Dynavax Technologies (DVAX)	United States	$0.430B	0.00
Gritstone Oncology (GRTS)	United States	$0.428B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.424B	0.00
MediciNova (MNOV)	United States	$0.421B	0.00
KALEIDO BIOSCI (KLDO)		$0.420B	0.00
Scholar Rock Holding (SRRK)	United States	$0.414B	0.00
Albireo Pharma (ALBO)	United States	$0.397B	0.00
Replimune (REPL)	United States	$0.396B	0.00
Kezar Life Sciences (KZR)	United States	$0.391B	0.00
Abeona Therapeutics (ABEO)	United States	$0.391B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.384B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.375B	0.00
Merus (MRUS)	Netherlands	$0.375B	0.00
Sinovac Biotech (SVA)	China	$0.371B	0.00
STEALTH BIOTHER (MITO)	United States	$0.370B	0.00
Senesco Technologies (ELOX)	United States	$0.366B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.355B	0.00
Agenus (AGEN)	United States	$0.352B	0.00
BeyondSpring (BYSI)	United States	$0.345B	0.00
BioDelivery Sciences (BDSI)	United States	$0.344B	0.00
Kindred Biosciences (KIN)	United States	$0.344B	0.00
UNITY Biotechnology (UBX)		$0.344B	0.00
AC Immune SA (ACIU)	Switzerland	$0.334B	0.00
Geron (GERN)	United States	$0.334B	0.00
Constellation Pharmaceuticals (CNST)	United States	$0.323B	0.00
Kadmon Holdings (KDMN)	United States	$0.320B	0.00
Biofrontera AG Sponsored ADR (BFRA)	Germany	$0.319B	0.00
XBiotech (XBIT)	United States	$0.318B	0.00
Solid Biosciences (SLDB)	United States	$0.316B	0.00
Cellular Biomedicine (CBMG)	United States	$0.309B	0.00
MannKind (MNKD)	United States	$0.304B	0.00
LogicBio Therapeutics (LOGC)	United States	$0.296B	0.00
Aduro Biotech (ADRO)	United States	$0.295B	0.00
Seres Therapeutics (MCRB)	United States	$0.286B	0.00
Kala Pharmaceuticals (KALA)	United States	$0.268B	0.00
Eiger BioPharmaceuticals (EIGR)	United States	$0.266B	0.00
Urovant Sciences (UROV)	United States	$0.265B	0.00
Enochian BioSciences (ENOB)	United States	$0.261B	0.00
Sutro Biopharma (STRO)	United States	$0.260B	0.00
Evelo Biosciences (EVLO)	United States	$0.260B	0.00
Kodiak Sciences (KOD)	United States	$0.259B	0.00
Novavax (NVAX)	United States	$0.257B	0.00
ResTORbio (TORC)	United States	$0.256B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.249B	0.00
Kamada (KMDA)	Israel	$0.247B	11.15
Protagonist Therapeutics (PTGX)	United States	$0.246B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.241B	0.00
Avid Bioservices (CDMO)	United States	$0.239B	0.00
Celcuity (CELC)	United States	$0.235B	0.00
Palatin Technologies (PTN)	United States	$0.231B	114.00
Xenon Pharmaceuticals (XENE)	Canada	$0.228B	0.00
ADMA Biologics Inc (ADMA)	United States	$0.225B	0.00
Cerecor (CERC)	United States	$0.221B	0.00
Aeglea BioTherapeutics (AGLE)	United States	$0.215B	0.00
ChromaDex (CDXC)	United States	$0.213B	0.00
Intec Pharma (NTEC)	Israel	$0.213B	0.00
Spero Therapeutics (SPRO)	United States	$0.212B	0.00
Mersana Therapeutics (MRSN)	United States	$0.211B	0.00
Synlogic (SYBX)	United States	$0.211B	0.00
OvaScience (MLND)	United States	$0.210B	0.00
Celyad SA (CYAD)	Belgium	$0.209B	0.00
TOCAGEN INC (TOCA)	United States	$0.208B	0.00
Athersys (ATHX)	United States	$0.207B	0.00
OSMOTICA PHARM (OSMT)	United States	$0.204B	0.00
CorMedix Inc (CRMD)	United States	$0.203B	0.00
VBI Vaccines (VBIV)	United States	$0.203B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.201B	0.00
Gamida Cell (GMDA)	Israel	$0.200B	0.00
Cel-Sci (CVM)	United States	$0.197B	0.00
Axovant Sciences (AXGT)	United Kingdom	$0.193B	0.00
BioTime (BTX)	United States	$0.193B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.192B	0.00
Compugen (CGEN)	Israel	$0.189B	0.00
Cue Biopharma (CUE)	United States	$0.184B	0.00
Pfenex (PFNX)	United States	$0.178B	0.00
Verastem (VSTM)	United States	$0.175B	0.00
Menlo Therapeutics (MNLO)	United States	$0.172B	0.00
Enzo Biochem (ENZ)	United States	$0.169B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.157B	0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT)	United States	$0.156B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.156B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.152B	0.00
Liquidia Technologies (LQDA)	United States	$0.151B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.148B	0.00
Chiasma (CHMA)	United States	$0.143B	0.00
Trevena (TRVN)	United States	$0.141B	0.00
Allena Pharmaceuticals (ALNA)	United States	$0.139B	0.00
Erytech Pharma SA Sponsored ADR (ERYP)	France	$0.139B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.136B	0.00
Anavex Life Sciences (AVXL)	United States	$0.135B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.133B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.131B	0.00
Aptinyx (APTX)	United States	$0.129B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.128B	0.00
VolitionRX (VNRX)	Singapore	$0.126B	0.00
Organovo Holdings (ONVO)	United States	$0.119B	0.00
XOMA (XOMA)	United States	$0.115B	0.00
Brainstorm Cell Therapeutics (BCLI)	United States	$0.114B	0.00
Cohbar (CWBR)	United States	$0.114B	0.00
Unum Therapeutics (UMRX)	United States	$0.113B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.113B	0.00
Selecta Biosciences (SELB)	United States	$0.112B	0.00
Neothetics (EVFM)	United States	$0.111B	0.00
Provention Bio (PRVB)	United States	$0.108B	0.00
Catalyst Biosciences (CBIO)	United States	$0.106B	0.00
SESEN BIO, INC (SESN)	United States	$0.105B	0.00
NantKwest (NK)	United States	$0.104B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.102B	0.00
INMUNE BIO INC (INMB)	United States	$0.102B	0.00
Equillium (EQ)	United States	$0.098B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.096B	0.00
Signal Genetics (MGEN)	United States	$0.090B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.088B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.086B	0.00
Cocrystal Pharma (COCP)	United States	$0.085B	90.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.084B	0.00
Alcobra (ARCT)	United States	$0.084B	0.00
Fortress Biotech (FBIO)	United States	$0.081B	0.00
Verona Pharma American Depositary Share (VRNA)	United Kingdom	$0.080B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.080B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.080B	0.00
Mustang Bio (MBIO)	United States	$0.080B	0.00
Eyenovia (EYEN)	United States	$0.077B	0.00
Tiziana Life Sciences Sponsored ADR (TLSA)	United Kingdom	$0.077B	0.00
Orgenesis (ORGS)	United States	$0.076B	0.00
Aptose Biosciences (APTO)	Canada	$0.074B	0.00
Alimera Sciences (ALIM)	United States	$0.072B	0.00
Idera Pharmaceuticals (IDRA)	United States	$0.072B	0.00
ARAVIVE, INC (ARAV)	United States	$0.072B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.072B	0.00
AEterna Zentaris (AEZS)	United States	$0.072B	17.40
Cidara Therapeutics (CDTX)	United States	$0.071B	0.00
OVID THERAPEUTC (OVID)	United States	$0.071B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.065B	0.00
Protalix BioTherapeutics (PLX)	Israel	$0.065B	0.00
Curis (CRIS)	United States	$0.064B	0.00
Vaccinex (VCNX)	United States	$0.064B	0.00
Apricus Biosciences (SEEL)	United States	$0.063B	0.00
NewLink Genetics (NLNK)	United States	$0.063B	0.00
Sienna Biopharmaceuticals (SNNA)	United States	$0.063B	0.00
VTv Therapeutics (VTVT)	United States	$0.061B	0.00
Evogene (EVGN)	Israel	$0.060B	0.00
Ophthotech (OPHT)	United States	$0.058B	0.00
Prima BioMed (IMMP)	Australia	$0.053B	0.00
ScPharmaceuticals (SCPH)	United States	$0.053B	0.00
Vascular Biogenics (VBLT)	Israel	$0.051B	0.00
Celldex Therapeutics (CLDX)	United States	$0.050B	0.00
ANCHIANO THERAP (ANCN)	Israel	$0.049B	0.00
Entera Bio (ENTX)	Israel	$0.049B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.049B	0.00
AquaBounty Technologies (AQB)	United States	$0.049B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.049B	0.00
AZURRX BIOPHARM (AZRX)	United States	$0.047B	0.00
Clearside Biomedical (CLSD)	United States	$0.046B	0.00
Bellerophon Therapeutics (BLPH)	United States	$0.046B	0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT)	United States	$0.046B	0.00
HOTH THERAPEUTC (HOTH)	United States	$0.046B	0.00
BiondVax Pharmaceuticals (BVXV)	Israel	$0.044B	0.00
Celsion (CLSN)	United States	$0.043B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.043B	0.00
Aerpio Pharmaceuticals (ARPO)	United States	$0.041B	0.00
Bionano Genomics (BNGO)	United States	$0.041B	0.00
OncoMed Pharmaceuticals (OMED)	United States	$0.039B	0.00
Zosano Pharma (ZSAN)	United States	$0.039B	0.00
OncoSec Medical (ONCS)	United States	$0.039B	0.00
Leap Therapeutics (LPTX)	United States	$0.037B	0.00
VIVUS (VVUS)	United States	$0.036B	0.00
Arsanis (XFOR)	United States	$0.036B	0.00
Aptevo Therapeutics (APVO)	United States	$0.035B	0.00
Motif Bio Plc (MTFB)	United States	$0.035B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.033B	0.00
Caladrius Biosciences (CLBS)	United States	$0.032B	0.00
Sophiris Bio (SPHS)	United States	$0.031B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.030B	0.00
GENPREX INC (GNPX)	United States	$0.028B	0.00
GTx (GTXI)	United States	$0.027B	0.00
Rexahn Pharmaceuticals (RNN)	United States	$0.027B	0.00
Moleculin Biotech (MBRX)	United States	$0.027B	0.00
Novelion Therapeutics (NVLN)	Canada	$0.026B	0.00
Aytu Bioscience (AYTU)	United States	$0.026B	0.00
Aileron Therapeutics (ALRN)	United States	$0.026B	0.00
Vical (VICL)	United States	$0.025B	0.00
Oragenics (OGEN)	United States	$0.025B	0.00
Galena Biopharma (SLS)	United States	$0.024B	0.00
Titan Pharmaceuticals (TTNP)	United States	$0.023B	0.00
Fibrocell Science Inc (FCSC)	United States	$0.022B	0.00
TRACON Pharmaceuticals (TCON)	United States	$0.022B	0.00
IMMURON LTD (IMRN)	Australia	$0.021B	0.00
ATyr Pharma (LIFE)	United States	$0.020B	0.00
Benitec Biopharma (BNTC)	Australia	$0.020B	0.00
CytRx (CYTR)	United States	$0.019B	0.00
Advaxis (ADXS)	United States	$0.019B	0.00
Gemphire Therapeutics (GEMP)	United States	$0.019B	0.00
Histogenics (HSGX)	United States	$0.018B	0.00
Oncobiologics (OTLK)	United States	$0.018B	0.00
Cleveland BioLabs (CBLI)	United States	$0.017B	0.00
Novogen (KZIA)	Australia	$0.017B	0.00
Prana Biotechnology (ATHE)	Australia	$0.016B	0.00
BioPharmX (BPMX)	United States	$0.016B	0.00
IBio (IBIO)	United States	$0.015B	0.00
TrovaGene (TROV)	United States	$0.014B	0.00
Alliqua BioMedical (ALQA)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
MYOS RENS Technology (MYOS)	United States	$0.013B	0.00
Genetic Technologies (GENE)	Australia	$0.013B	0.00
Cyclacel Pharmaceuticals (CYCC)	United States	$0.013B	0.00
Dare Bioscience (DARE)	United States	$0.012B	0.00
Therapix Biosciences (TRPX)	Israel	$0.012B	5.91
AmpliPhi Biosciences (APHB)	United States	$0.012B	0.00
RestorGenex (DFFN)	United States	$0.011B	0.00
Flex Pharma (FLKS)	United States	$0.011B	0.00
Tenax Therapeutics (TENX)	United States	$0.010B	0.00
Proteon Therapeutics (PRTO)	United States	$0.010B	0.00
Edge Therapeutics (PDSB)	United States	$0.010B	0.00
Synthetic Biologics (SYN)	United States	$0.010B	0.00
Hemispherx BioPharma (HEB)	United States	$0.009B	0.00
Pulmatrix (PULM)	United States	$0.009B	0.00
Neuralstem (CUR)	United States	$0.008B	0.00
ARCA Biopharma (ABIO)	United States	$0.006B	0.00
Cytori Therapeutics Inc (CYTX)	United States	$0.006B	0.00
Stellar Biotechnologies (SBOT)	United States	$0.006B	0.00
Cellect Biotechnology (APOP)	Israel	$0.005B	0.00
ContraVir Pharmaceuticals Inc (CTRV)	United States	$0.005B	0.00